癫痫市场规模预计将从 2022 年的 77 亿美元增长到 2030 年的 107 亿美元;预计 2022-2030 年的复合年增长率为 4.1%。推动市场增长的关键因素是癫痫患病率上升和对癫痫治疗开发的投资增加。然而,产品召回可能会在一定程度上阻碍市场增长。
癫痫市场分析
癫痫又称癫痫症,是一种影响大脑的慢性非传染性疾病。癫痫影响所有种族、民族背景、性别和年龄的人。根据疾病控制和预防中心的数据,估计美国有 1.2% 的人患有活动性癫痫。
癫痫市场概况
癫痫可能由于某些遗传性疾病而发生,也可能由于某些后天性脑损伤(例如创伤或中风)而发生。根据世界卫生组织 (WHO) 于 2023 年 2 月发布的最新报告,癫痫占全球疾病负担的很大一部分,影响着全球近五千万人。此外,估计每 1,000 人中就有 4-10 人患有活动性癫痫(即需要治疗或持续癫痫发作)。每年有近 500 万人被诊断出患有癫痫。据估计,高收入国家每年报告的癫痫发病率为每 100,000 人 49 人。在中低收入国家,这一数字可能达到每 100,000 人 139 人。癫痫发病率的上升可归因于道路交通伤害和出生相关伤害的数量增加,以及神经囊虫病或疟疾等地方病风险增加。世界卫生组织还指出,大约 70% 的癫痫患者可以通过药物治疗摆脱癫痫发作。
控制癫痫的治疗方法包括抗癫痫药物、特殊饮食(除抗癫痫药物外)和手术;然而,抗癫痫药物治疗是大多数患者的主要治疗方法。因此,全球癫痫患病率的上升推动了市场的增长。
定制此报告以满足您的需求
您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣
- 获取此报告的关键市场趋势。这个免费样品将包括数据分析,从市场趋势到估计和预测。
癫痫市场的驱动因素和机遇
加大对癫痫治疗开发的投资有利于市场
随着技术的快速发展和创新,医疗保健行业正在发生转变,医疗保健服务和护理质量也得到了提升。癫痫市场的特点是,许多大大小小的公司和组织都在实施各种增长战略。资金的充足使得公司和组织能够提高生产水平、拓展新市场、投资新技术/改进技术,并为研发分配更多资源。以下是一些对癫痫市场做出重大贡献的投资,这些投资有助于推动市场发展
- 2023年3月,瑞典政府决定向瑞典创新机构Vinnova投资总计770万美元(8000万瑞典克朗),建立国家创新集群,用于细胞疗法和基因疗法等其他先进疗法的商业化、技能开发和生产能力建设。
- 2022 年 11 月,英国阿斯顿大学的科学家正在开展一项旨在开发预防儿童癫痫发作的新药物疗法的项目,他们获得了 240 万美元(200 万英镑)的资助,用于研究大脑中的疾病机制和预防癫痫的方法。这个为期 3 年的项目由医学研究委员会资助,是由阿斯顿大学健康与生命科学学院的研究人员与布里斯托大学和 Jazz Pharmaceutical 合作开展的。
组织开展的认知计划——癫痫市场的机会
人们对癫痫及其症状以及早期诊断的重要性的认识不断提高,导致寻求医疗救治的患者数量激增。癫痫基金会、癫痫学会、美国癫痫学会和佛罗里达中部癫痫协会等组织在教育人们了解这种疾病方面发挥着至关重要的作用。这些组织的参与提高了诊断率,并扩大了需要癫痫治疗的患者群体。
全球各地的组织开展了大量宣传活动,以传播有关癫痫状况和可用治疗方法的意识。在美国,每年的 3 月 26 日是癫痫宣传日或紫色日,以提高公众对这种脑部疾病的了解,同时消除人们对癫痫的恐惧和耻辱感。同样,每年的 11 月都被定为美国全国癫痫宣传月 (NEAM),以教育人们了解癫痫的状况和症状,并为与治疗这种疾病相关的研究筹集资金。癫痫基金会选择一个主题,鼓励人们合作并采取行动,以提高人们对癫痫的认识并筹集资金。2021 年 11 月,该基金会发起了 #RemoveTheFilter 社交媒体活动,以减少与癫痫相关的恐惧,并为患有癫痫的人带来希望。
此外,癫痫基金会与 SK Life Science Inc. 合作,推出了 30 分钟的点播课程,让人们学习癫痫急救的基本知识。10 月 23 日是英国癫痫猝死 (SUDEP) 宣传日。SUDEP 行动引导国际癫痫界认识并提高对癫痫猝死和意外死亡的认识。因此,此类举措和宣传活动增加了癫痫的诊断和治疗,为市场提供了丰厚的增长机会。
癫痫市场报告细分分析
有助于得出癫痫市场分析的关键部分是类型、给药途径、治疗类型、年龄组和分销渠道。
- 根据类型,癫痫市场分为进行性肌阵挛性癫痫、反射性癫痫、全身性癫痫等。全身性癫痫部分在 2022 年占据了更高的市场份额。
- 根据给药途径,市场分为口服、肠胃外、其他给药途径。
- 按照治疗类型,市场分为第一代药物、第二代药物和第三代药物。
- 按照年龄段来看,市场分为成人和儿童。
- 就分销渠道而言,市场细分为医院药店、零售药店和其他分销渠道
癫痫市场份额按地区分析
癫痫市场报告的地理范围主要分为五个地区:北美、亚太、欧洲、中东和非洲、南美/南美和中美。
在北美,癫痫市场在预测年份内目前正在经历指数级增长。2022 年,美国市场将主导全球癫痫市场。阿尔茨海默病等神经系统疾病病例数量的激增、人们对神经系统疾病的认识不断提高、研究活动取得的良好成果以及对开发癫痫药物的投资不断增加,是推动美国整体癫痫市场增长的主要因素。2020 年 3 月,Neurelis, Inc. 宣布 VALTOCO(地西泮鼻喷雾剂)投入商业使用,用于治疗与儿童和成人患者通常观察到的癫痫发作模式不同的刻板、间歇性频繁癫痫发作(即急性重复性癫痫发作和癫痫丛集)。同样,2022 年 3 月,FDA 批准 Ztalmy(加奈索酮)用于治疗 2 岁及以上患者的细胞周期依赖性蛋白激酶样 5 (CDKL5) 缺乏症 (CDD) 相关的癫痫发作。
2021 年 8 月,CDC 癫痫项目根据一项新的合作协议选择癫痫基金会作为其资助接受者:通过国家和社区伙伴关系改善护理系统、癫痫教育和健康结果。未来 5 年将拨出的 1750 万美元联邦资金将支持癫痫基金会及其合作伙伴的工作,以创建和维护强大的公共卫生基础设施、促进健康公平、改善生活质量并为所有癫痫患者实现最佳结果。因此,癫痫患病率的不断上升、新药的推出以及研究和资助计划增强了美国癫痫市场的规模。
癫痫市场区域洞察
Insight Partners 的分析师已详尽解释了预测期内影响癫痫市场的区域趋势和因素。本节还讨论了北美洲、欧洲、亚太地区、中东和非洲以及南美洲和中美洲的癫痫市场细分和地理位置。
- 获取癫痫市场的区域特定数据
癫痫市场报告范围
报告属性 | 细节 |
---|---|
2022 年市场规模 | 77亿美元 |
2030 年的市场规模 | 107亿美元 |
全球复合年增长率(2022 - 2030 年) | 4.1% |
史料 | 2020-2021 |
预测期 | 2022-2030 |
涵盖的领域 | 按类型
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
市场参与者密度:了解其对商业动态的影响
癫痫市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。
市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明相对于给定市场空间的规模或总市场价值,有多少竞争对手(市场参与者)存在于该市场空间中。
在癫痫市场运营的主要公司有:
- Idexx 实验室公司
- PBD生物科技有限公司
- 赛默飞世尔科技公司
- 创新诊断 SAS
- 尼奥金公司
- Enfer 实验室
免责声明:上面列出的公司没有按照任何特定顺序排列。
- 了解癫痫市场的主要参与者概况
癫痫市场新闻和最新发展
通过收集主要和次要研究后的定性和定量数据来评估癫痫市场,其中包括重要的公司出版物、协会数据和数据库。以下是市场创新、业务扩展和战略发展情况的列表:
- 2023 年 5 月,专注于寻找和开发治疗中枢神经系统疾病的新型药物的生物技术公司 Neuro3 Therapeutics (Neuro3) 与 Lundbeck 签署了独家全球许可和选择权协议。该协议重点关注 KCNQ2 离子通道激活剂,该药物已被临床验证为治疗癫痫的靶点。根据临床研究,KCNQ2 通道激活可能为治疗各种神经系统疾病(例如罕见形式的癫痫)提供治疗替代方案。(来源:Neuro3 Therapeutics 公司网站)
癫痫市场报告覆盖范围和交付成果
“癫痫市场规模和预测(2020-2030 年)”报告对市场进行了详细分析,涵盖以下领域:
- 癫痫市场规模及全球、区域和国家层面所有主要细分市场的预测
- 市场动态,如驱动因素、限制因素和关键机遇
- 癫痫市场趋势
- 详细的 PEST/波特五力分析和 SWOT 分析
- 癫痫市场分析涵盖主要市场趋势、全球和区域框架、主要参与者、法规和最新市场发展
- 癫痫行业格局和竞争分析,涵盖市场集中度、热图分析、知名参与者和最新发展
- 详细的公司简介
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The market is expected to register a CAGR of 4.10% during 2023–2031.
Abbott Laboratories, Pfizer Inc., Eisai Co Ltd., UCB SA, CombiGene AB, LivaNova Plc, Novartis AG, Medtronic Plc, GSK Plc, and H. Lundbeck AS
The high-throughput genetic sequencing technique enables a faster and more comprehensive analysis of DNA, thereby aiding the identification of genetic causes of conditions such as epilepsy are likely to remain a key trend in the market.
The rising prevalence of epilepsy and increasing investments in development of epilepsy therapies are the major factors fuelling the market growth of epilepsy over the years.
North America dominated the epilepsy market in 2023
Trends and growth analysis reports related to Life Sciences : READ MORE..
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.